UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 9,000 people in approximately 40 countries, the company generated revenue of € 6.1 billion in 2024. UCB is listed on Euronext Brussels (symbol: UCB).Content by UCB
| 3 min read
The partnership leverages real-world patient data and advanced analytics to support faster, more patient-centered drug discovery.
Page 1 of 1 - 1 Total Items
